SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalia Therapeutics Plc Share Price (THAT.GB.PL)

Share Price Information for Thalia Therapeutics Plc (THAT.GB.PL)

Share Price is delayed by 15 minutes
Get Live Data
0.625    0.00 (0.00%)
Bid:
0.50
Ask:
0.75
Spread: 0.25 (50.00%)
Market Cap: £466.96k
THAT.GB.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Thalia Therapeutics Plc Share Chart

Thalia Therapeutics Plc Share Price
Price 0.625 Open 0.625
Bid 0.50 High 0.625
Ask 0.75 Low 0.625
Change 0.00 (0.00%) Close 0.625
Volume 0
Currency GBX
Issue Country GB
Shares in Issue 74.71m
Market Cap £466.96k
PE Ratio 0.00
EPS 0.00
Year High 0.925
Year High Date 13-Apr-2026
Year Low 0.45
Year Low Date 13-Apr-2026
Dividend 0.00
Yield 0.00%
# Trades 0
Vol. Sold 0
Sold Value £N/A
Vol. Bought 0
Bought Value £N/A
Market Size 0
What if I invested £1,000 in Thalia Therapeutics Plc?
£ 925.93 (-7.41%)
1 month ago
Add THAT.GB.PL to WatchlistAdd THAT.GB.PL to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Thalia Therapeutics Plc

Thalia Therapeutics Plc is listed on the Aquis Stock Exchange trading with ticker code THAT.GB.PL. It has a market capitalisation of £466.96k, with approximately 74.71m shares in issue. Over the last year, Thalia Therapeutics Plc share price has been traded in a range of 0.475, hitting a high of 0.925, and a low of 0.45.

Recent Share Trades for Thalia Therapeutics Plc (THAT.GB.PL)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
  • No trades found.
  • This chat board is for this share's listing on the Aquis Stock Exchange.
  • There are no chat posts for Thalia Therapeutics Plc